China & RTP’s Brii Biosciences Selected by NIAID for Combo Monoclonal Antibody Clinical Trial Targeting COVID-19
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), continues to invest […]